China Universal Asset Management Company’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Buy	14,923 +1,136	+8%	+$101K	0.12%	132
2025 Q4	$1.2M	Sell	13,787 -2,118	-13%	-$173K	0.09%	172
2025 Q3	$1.06M	Sell	15,905 -3,003	-16%	-$171K	0.09%	176
2025 Q2	$1.05M	Buy	18,908 +136	+0.7%	+$6.53K	0.1%	160
2025 Q1	$908K	Buy	18,772 +6,135	+49%	+$257K	0.08%	199
2024 Q4	$488K	Buy	12,637 +1,308	+12%	+$57K	0.05%	253
2024 Q3	$510K	Buy	11,329 +4,438	+64%	+$179K	0.06%	214
2024 Q2	$239K	Sell	6,891 -4,301	-38%	-$126K	0.03%	215
2024 Q1	$324K	Buy	11,192 +4,517	+68%	+$123K	0.04%	232
2023 Q4	$153K	Buy	6,675 +5,202	+353%	+$91K	0.03%	234
2023 Q3	$24.6K	Buy	1,473 +723	+96%	+$14K	0.01%	287
2023 Q2	$20.7K	Buy	750 +83	+12%	+$2.08K	0.01%	265
2023 Q1	$15.3K	Buy	667 +167	+33%	+$2.81K	0.01%	247
2022 Q4	$5.46K	Buy	500 +40	+9%	+$337	﹤0.01%	288
2022 Q3	$4K	Buy	+460	New	+$4.35K	﹤0.01%	308